Biomedical testing solutions, MB - financials and debts

Company age: 2 y. 11 mo.

Update

Biomedical testing solutions - Company finances

  • The company is late in submitting financial data for the previous financial year.
  • The company has not submitted financial data for these years: 2024.
  • Latest financial data up to 2023-12-31.
EUR
2023
From: 2023-11-01
To: 2023-12-31
Financial data
Sales revenue -
Profit before tax -14
Net profit -14
Equity -10
Liabilities 23
Non-current assets 0
Current assets 13
Total assets 13
Taxes paid
STI taxes 3
Financial indicators
Revenue change y/y -
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -107.7%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. -
Profit margin Net profit margin. Shows the overall profitability of the company. -
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Biomedical testing solutions - Social security debts

From To Debt, €
2026-02-03 2026-02-28 297.81
2026-01-01 2026-02-02 217.33
2025-12-02 2025-12-31 144.88
2025-11-01 2025-12-01 72.43
2024-01-23 2024-02-07 1.62
2024-01-15 2024-01-22 1.61
2023-12-19 2024-01-11 1.61

Biomedical testing solutions - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.